FDA panel backs Glaxo's cervical vaccine for women

Wednesday, September 9, 2009 - 16:56 in Health & Medicine

WASHINGTON (AP) -- Drugmaker Merck likely will face U.S. competition for its vaccine Gardasil, after federal experts recommended rival GlaxoSmithKline's Cervarix also be approved to prevent the virus that causes most cervical cancers....

Read the whole article on AP Health

More from AP Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net